We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Report on non-fatal overdose monitoring data collected from the unlinked anonymous monitoring survey of HIV, hepatitis B and hepatitis C in people who inject drugs.
Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without delay
Veriton Pharma Limited is recalling a specific batch of Epistatus (midazolam) 2.5mg Oromucosal Solution (pre-filled oral syringes) due to confirmed out of specification results related to the product appearance.
Information for drug services to help them prevent, identify, treat and manage wounds in people who inject drugs.
Monitoring significant occupational exposures to HIV, hepatitis B and hepatitis C in healthcare workers, and advising on avoiding injuries.
The overall prevalence of HIV includes the number of diagnosed as well as undiagnosed people infected with HIV.
Advice for people who inject drugs (PWID) on reducing the risk of wound botulism.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).